Zoster scleritis is an inflammatory condition of the sclera associated with herpes zoster infection. It can lead to significant ocular complications, including vision loss. Accurate coding with ICD-10 Code B02.34 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
What is ICD-10 Code B02.34 for Zoster scleritis?
ICD-10 Code B02.34 specifically denotes Zoster scleritis, which is an inflammation of the sclera resulting from reactivation of the varicella-zoster virus. This code should be used in clinical documentation and billing when a patient presents with ocular symptoms related to herpes zoster, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
ICD-10 Code B02.34 – Clinical Definition and Explanation of Zoster scleritis
Zoster scleritis is caused by the reactivation of the varicella-zoster virus, leading to inflammation of the sclera. This condition can progress rapidly and may result in severe complications, necessitating prompt medical attention to prevent vision impairment.
Key Clinical Features:
- Ocular pain and redness
- Photophobia
- Decreased visual acuity
- History of herpes zoster infection
ICD-10 Code B02.34 for Zoster scleritis – SOAP Notes & Clinical Use
In SOAP notes, ICD-10 Code B02.34 is utilized to document the patient's symptoms, assessment findings, and treatment plans related to Zoster scleritis. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management.
What Does ICD-10 Code B02.34 for Zoster scleritis Mean in SOAP Notes?
ICD-10 Code B02.34 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Zoster scleritis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code B02.34 – Zoster scleritis
Zoster scleritis requires prompt treatment to mitigate inflammation and prevent complications. Hospitalization may be necessary in severe cases.
Antibiotic Therapy:
- Acyclovir 800 mg orally five times daily for 7-10 days
- Valacyclovir 1 g orally three times daily for 7-10 days
- Famciclovir 500 mg orally three times daily for 7-10 days
Supportive Care:
- Topical corticosteroids to reduce inflammation
- Pain management with NSAIDs
- Regular ophthalmologic follow-up
Infection Control:
- Isolate patients during acute outbreaks
- Educate on hygiene practices to prevent spread
- Monitor for secondary infections
How to Document Symptoms of Zoster scleritis (ICD-10 B02.34) in SOAP Notes
Subjective:
- Patient reports ocular pain and redness
- History of recent herpes zoster rash
- Complaints of photophobia and blurred vision
Objective:
- Visual acuity measured at 20/40
- Scleral injection observed on examination
- Presence of vesicular lesions on the eyelid
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Zoster scleritis (ICD-10 Code B02.34)
Assessment:
- Diagnosis: Zoster scleritis, moderate severity
- ICD-10 Code: B02.34
- Contributing factors: Recent herpes zoster infection
Plan:
- Initiate antiviral therapy with acyclovir
- Prescribe topical corticosteroids
- Schedule follow-up in one week for reassessment
Treatment & Plan Section for ICD-10 Code B02.34 – Zoster scleritis
- First-line antiviral therapy (e.g., acyclovir)
- Topical corticosteroids for inflammation
- Patient education on symptom management
- Regular follow-up to monitor treatment response
Using ICD-10 Code B02.34 for Zoster scleritis in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and history
- Use B02.34 in appropriate clinical settings for billing
- Align treatment plans with clinical guidelines for reimbursement
- Document any related procedures or services performed
Related ICD-10 Codes Often Used with Zoster scleritis
- B02.33 – Zoster keratitis
- B02.32 – Zoster conjunctivitis
- B02.30 – Zoster ophthalmicus
- B02.31 – Zoster uveitis
ICD-10 Code B02.34 in Medical Billing and Insurance for Zoster scleritis
ICD-10 Code B02.34 is crucial for billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant symptoms and history for accurate coding
- Use B02.34 in conjunction with other related codes as necessary
- Ensure compliance with payer guidelines for reimbursement
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 92002 | Ophthalmological examination, new patient, low complexity |
| 92004 | Ophthalmological examination, new patient, high complexity |
| 92012 | Ophthalmological examination, established patient, low complexity |
Frequently Asked Questions
Common Questions About Using ICD-10 Code B02.34 for Zoster scleritis
What are the common symptoms of Zoster scleritis?
Common symptoms include ocular pain, redness, photophobia, and decreased visual acuity. Patients may also report a history of herpes zoster infection.
Is Zoster scleritis contagious?
Zoster scleritis itself is not contagious; however, the underlying varicella-zoster virus can be transmitted to individuals who have not had chickenpox or the vaccine.
When should I use ICD-10 Code B02.34?
ICD-10 Code B02.34 should be used when a patient presents with symptoms of scleritis associated with a history of herpes zoster infection.
What is the treatment for Zoster scleritis?
Treatment typically includes antiviral medications, topical corticosteroids, and pain management. Early intervention is crucial to prevent complications.
